<DOC>
	<DOCNO>NCT01680575</DOCNO>
	<brief_summary>To develop robust prediction model predict occurrence grade 3-4 neutropenia induce adjuvant paclitaxel/carboplatin chemotherapy patient epithelial ovarian cancer validate model .</brief_summary>
	<brief_title>Study Neutropenia Induced Adjuvant Paclitaxel/Carboplatin Chemotherapy Patients With Epithelial Ovarian Cancer</brief_title>
	<detailed_description />
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Neoplasms , Glandular Epithelial</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>Patients FIGO stage IIV epithelial ovarian cancer stag debulking surgery Patients plan receive ( prospective cohort ) ro receive ( retrospective cohort ) adjuvant chemotherapy paclitaxel carboplatin Patients sign approve informed consent Uncontrolled medical disease Active infectious disease Previous pelvic radiation therapy Previous chemotherapy ( prospective cohort ) Patients disease cause neutropenia Patients receive target therapy immunotherapy adjuvant therapy ( prospective cohort ) . Pregnant lactate woman</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Neutropenia</keyword>
	<keyword>Paclitaxel</keyword>
	<keyword>Carboplatin</keyword>
	<keyword>Epithelial ovarian cancer</keyword>
</DOC>